About
Senseye Ltd develops and commercializes surface plasmon resonance (SPR) sensor technology for detecting and analyzing biological interactions, including highly sensitive COVID-19 antibody screening tools.
Explore Senseye Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.